Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

2.950 +0.080 (+2.79%)
Streaming Delayed Price Updated: 9:33 AM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
22 23 Next >
News headline image
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Forecasting The Future: 4 Analyst Projections For Iovance Biotherapeutics ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
 
Via Benzinga
News headline image
Uncovering Potential: Iovance Biotherapeutics's Earnings Preview ↗
 
Via Benzinga
News headline image
My 3 Favorite Stocks to Buy Right Now ↗
There are plenty of good ones to choose from, but these three are all undervalued, leaving them ripe for a lot of bullishness sooner than later. 
Via The Motley Fool
News headline image
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
2 Beaten-Down Stocks With Incredible Upside Potential ↗
Via The Motley Fool
News headline image
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year. ↗
Via The Motley Fool
News headline image
This Biotech Stock Could Be the Best Investment of the Decade ↗
There's an incredible growth story hiding in plain sight for investors who can look to the future. 
Via The Motley Fool
News headline image
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Is Iovance Biotherapeutics a Millionaire-Maker? ↗
Via The Motley Fool
News headline image
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street ↗
Via The Motley Fool
News headline image
Traws Pharma Announces Management Updates
From Traws Pharma, Inc.
Via GlobeNewswire
News headline image
Top 3 Health Care Stocks That Are Set To Fly This Month ↗
 
Via Benzinga
News headline image
1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street ↗
Via The Motley Fool
News headline image
3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not ↗
The time to buy quality prospects is when the rest of the market is ignoring their value. 
Via The Motley Fool
News headline image
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up? ↗
Via The Motley Fool
News headline image
These stocks are moving in today's after hours session ↗
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
News headline image
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
My 3 Favorite Stocks to Buy Right Now ↗
The market's underestimating how well each of these companies should be able to capitalize on their opportunities. 
Via The Motley Fool
News headline image
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Iovance Biotherapeutics Shares Fell Today: What's Going On? ↗
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares closed lower on Monday potentially following the company's announcement of Dan Kirby as Chief Commercial Officer. 
Via Benzinga
News headline image
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.